1. Home
  2. MYO vs INMB Comparison

MYO vs INMB Comparison

Compare MYO & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myomo Inc.

MYO

Myomo Inc.

N/A

Current Price

$1.23

Market Cap

63.8M

Sector

Health Care

ML Signal

N/A

Logo INmune Bio Inc.

INMB

INmune Bio Inc.

N/A

Current Price

$1.04

Market Cap

64.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYO
INMB
Founded
2004
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.8M
64.7M
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
MYO
INMB
Price
$1.23
$1.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$4.64
★ $7.00
AVG Volume (30 Days)
215.2K
★ 276.8K
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 11.85
EPS
★ N/A
N/A
Revenue
★ $1,000,000,000.00
$50,000.00
Revenue This Year
$13.25
N/A
Revenue Next Year
$10.45
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 40814.79
257.14
52 Week Low
$0.61
$1.01
52 Week High
$1.89
$2.60

Technical Indicators

Market Signals
Indicator
MYO
INMB
Relative Strength Index (RSI) 45.54 24.18
Support Level $1.17 N/A
Resistance Level $1.75 $1.52
Average True Range (ATR) 0.11 0.11
MACD 0.01 -0.02
Stochastic Oscillator 22.58 6.25

Price Performance

Historical Comparison
MYO
INMB

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.

About INMB INmune Bio Inc.

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

Share on Social Networks: